Cormedix CRMD is set to give its latest quarterly earnings report on Wednesday, 2024-10-30. Here's what investors need to know before the announcement.
Analysts estimate that Cormedix will report an earnings per share (EPS) of $-0.10.
Cormedix bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Earnings History Snapshot
In the previous earnings release, the company missed EPS by $0.00, leading to a 2.54% drop in the share price the following trading session.
Here's a look at Cormedix's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.25 | -0.28 | -0.20 | -0.21 |
| EPS Actual | -0.25 | -0.25 | -0.26 | -0.17 |
| Price Change % | -3.0% | -4.0% | 14.000000000000002% | 6.0% |
Tracking Cormedix's Stock Performance
Shares of Cormedix were trading at $13.59 as of October 28. Over the last 52-week period, shares are up 282.91%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.
To track all earnings releases for Cormedix visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
